Reports
Sale
Global Drugs of Abuse Testing Market Size, Trends, Forecast: By Product Type: Analyzers, Rapid Testing Devices, Consumables, Others; By Sample Type: Saliva, Urine, Blood, Others; By End Users: Hospitals, Diagnostics Laboratories, Forensic Laboratories, Others; Regional Analysis; Patent Analysis; Supplier Landscape; 2024-2032
Global Drugs of Abuse Testing Market Outlook
The global drugs of abuse testing market size was valued at USD 6.64 billion in 2023. The major drivers of the market include the presence of prominent players, increasing prevalence of substance abuse, drug of abuse testing device companies, rising risk of drug dependence and substance use disorder, increasing incidence of opioid dependence, and technological advancements in drug screening/testing devices. The market is anticipated to grow at a CAGR of 7.1% during the forecast period 2024-2032 to reach a value of USD 12.31 billion by 2032.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
North America to be a Significant Regional Market for Drugs of Abuse Testing
North America is anticipated to be the largest regional market primarily because of the presence of prominent players undertaking extensive expansion strategies. Its dominant share could also be attributed to the rising prevalence of substance abuse in the region and government initiatives to control it. The rising rate of substance use disorder owin to the COVID-19 pandemic is anticipated to augment the demand for drug of abuse testing services in the region. However, nationwide lockdowns due to COVID-19 are expected to reduce the demand for workplace drug testing services, thus leading to sluggish market growth. Regional growth can also be attributed to the strong presence of drug of abuse testing device companies, along with progressing regulatory framework. Various federal government sources, including regulations, guidance, and public notices, provide essential information on drug substances favouring public health.
Further, the growing government initiative to trace the use of drugs among the population is facilitating the adoption of drug of abuse testing. For instance, the United States government implemented the Patients and Communities Act to counter the problem of drug abuse.
Market Segmentations
Drugs of abuse are compounds that have a specific effect on the user's brain, primarily in the reward circuitry. Drugs of abuse, in general, create either positive or negative feelings within seconds to minutes of administration. Drug tests, in general, do not detect drug use. On the other hand, drug tests identify specific drug classes or substances in biological matrices represented in specific test panels.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Based on products and services, the drugs of abuse market can be divided into:
- Analysers
- Consumables
- Rapid Testing Devices
- Laboratory Services
By sample type, the market is divided into:
- Urine
- Oral Fluid (Saliva)
- Hair
- Breath
- Others
The end-users of the market are:
- Workplaces and Schools
- Criminal Justice Systems and Law Enforcement Agencies
- Research Laboratories
- Hospitals
The regional markets for the drugs of abuse testing market can be divided into North America, Europe, the Asia Pacific, Latin America, the Middle East and Africa.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Increase in the Consumption of Illicit Drugs Augmenting the Market Growth
The rapid rise in the consumption of alcohol and illicit drugs has led to the market's high growth. Opiates, cocaine, cannabinoids, lysergic acid diethylamide (LSD), barbiturates, amphetamines, alcohol, diazepam, and ketamine are frequently misused for their mind-altering properties, non-therapeutic and medicinal uses, and other goals, such as weight loss and sports performance enhancement. One of the leading causes driving the demand for drug of abuse testing worldwide is the risk of drug dependence and substance use disorder. As the incidence of opioid dependence continues to rise, healthcare professionals and other medical institutes are running regular tests and screening of the elderly to diagnose signs of drug abuse at an early stage. This is expected to spur the demand for drugs of abuse testing tools and equipment in hospitals and diagnostics. Various government programmes are designed to monitor and combat substance usage. Thus, the rise in government initiatives to monitor and combat substance abuse is also significantly driving the market. In addition, prominent companies provide automated testing and analysis for illicit drugs. These companies are also giving at-home kits for rapid drug misuse tests, which is fuelling the expansion of the global market.
Key Players in the Global Drugs of Abuse Testing Market
The report gives a detailed analysis of the following key players in the global drugs of abuse testing market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:
- Lifeloc Technologies, Inc
- Abbott Laboratories.
- F. Hoffmann-La Roche Ltd
- Bio-Rad Laboratories, Inc.
- Quest Diagnostics
- Premier Biotech, Inc.
- Others
The comprehensive EMR report provides an in-depth assessment of the market based on the Porter's five forces model along with giving a SWOT analysis.
Key Highlights of the Report
| REPORT FEATURES | DETAILS |
| Base Year | 2023 |
| Historical Period | 2017-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Product Type |
|
| Breakup by Sample Type |
|
| Breakup by End Users |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
| Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
| Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Drugs of Abuse Testing Market Overview
3.1 Drugs of Abuse Testing Market Historical Value (2017-2023)
3.2 Drugs of Abuse Testing Market Forecast Value (2024-2032)
4 Drugs of Abuse Testing Market Landscape
4.1 Drugs of Abuse Testing: Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Drugs of Abuse Testing Product Landscape
4.2.1 Analysis by Device Type
4.2.2 Analysis by Technology
4.2.3 Analysis by End User
5 Drugs of Abuse Testing Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Drugs of Abuse Testing Market Segmentation
6.1 Drugs of Abuse Testing Market by Product Type
6.1.1 Market Overview
6.1.2 Analyzers
6.1.2.1 Market Overview
6.1.2.2 Immunoassay Analyzers
6.1.2.3 Chromatographic Devices
6.1.2.4 Breath Analyzers
6.1.3 Rapid Testing Devices
6.1.3.1 Market Overview
6.1.3.2 Urine Testing Devices
6.1.3.3 Oral Fluid Testing Devices
6.1.4 Consumables
6.1.5 Others
6.2 Drugs of Abuse Testing Market by Sample Type
6.2.1 Market Overview
6.2.2 Saliva
6.2.3 Urine
6.2.4 Blood
6.2.5 Others
6.3 Drugs of Abuse Testing Market by End Users
6.3.1 Market Overview
6.3.2 Hospitals
6.3.3 Diagnostics Laboratories
6.3.4 Forensic Laboratories
6.3.5 Others
6.4 Drugs of Abuse Testing Market by Region
6.4.1 Market Overview
6.4.2 North America
6.4.3 Europe
6.4.4 Asia Pacific
6.4.5 Latin America
6.4.6 Middle East and Africa
7 North America Drugs of Abuse Testing
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Drugs of Abuse Testing
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Drugs of Abuse Testing
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others
10 Latin America Drugs of Abuse Testing
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Drugs of Abuse Testing
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Regulatory Framework
12.1 Regulatory Overview
12.1.1 US FDA
12.1.2 EU EMA
12.1.3 INDIA CDSCO
12.1.4 JAPAN PMDA
12.1.5 Others
13 Patent Analysis
13.1 Analysis by Type of Patent
13.2 Analysis by Publication year
13.3 Analysis by Issuing Authority
13.4 Analysis by Patent Age
13.5 Analysis by CPC Analysis
13.6 Analysis by Patent Valuation
13.7 Analysis by Key Players
14 Grants Analysis
14.1 Analysis by year
14.2 Analysis by Amount Awarded
14.3 Analysis by Issuing Authority
14.4 Analysis by Grant Application
14.5 Analysis by Funding Institute
14.6 Analysis by NIH Departments
14.7 Analysis by Recipient Organization
15 Funding and Investment Analysis
15.1 Analysis by Funding Instances
15.2 Analysis by Type of Funding
15.3 Analysis by Funding Amount
15.4 Analysis by Leading Players
15.5 Analysis by Leading Investors
15.6 Analysis by Geography
16 Partnership and Collaborations Analysis
16.1 Analysis by Partnership Instances
16.2 Analysis by Type of Partnership
16.3 Analysis by Leading Players
16.4 Analysis by Geography
17 Supplier Landscape
17.1 Danaher Corporation (Beckman Coulter, Inc.)
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.1.5 Certifications
17.2 Quest Diagnostics Inc.
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 LabCorp
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 Drägerwerk AG & Co. KGaA
17.4.1 Financial Analysis
17.4.2 Product Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 Abbot Laboratories
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 Express Diagnostics International INC
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 F. HOFFMANN-LA ROCHE LTD. (GENENTECH INC.)
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 Laboratory Corporation Of America Holdings
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 Quest Diagnostics Incorporated
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 Siemens AG
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
17.11 Thermo fisher Scientific inc.
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisitions
17.11.5 Certifications
18 Drugs of Abuse Testing - Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
Key Questions Answered in the Report
The global drugs of abuse testing market reached a value of USD 6.64 billion in 2023.
The market is projected to grow at a CAGR of 7.1% during the forecast period of 2024-2032 to reach a value of USD 12.31 billion by 2032.
The major drivers of the market include the presence of prominent players, increasing prevalence of substance abuse, drug of abuse testing device companies, rising risk of drug dependence and substance use disorder, increasing incidence of opioid dependence, and technological advancements in drug screening/testing devices.
An increase in the consumption of alcohol and illicit drugs and a rise in government initiatives are the key industry trends propelling the market's growth.
The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.
The market is divided into analysers, consumables, rapid testing devices, and laboratory services based on products and services.
Based on sample type, the market is divided into urine, oral fluid (saliva), hair, and breath, among others.
The end-users of the market are workplaces and schools, criminal justice systems and law enforcement agencies, research laboratories, and hospitals.
The major players in the industry are Lifeloc Technologies, Inc, Abbott Laboratories., F. Hoffmann-La Roche Ltd, Bio-Rad Laboratories, Inc., Quest Diagnostics, and Premier Biotech, Inc., among others.
Purchase Options 10% off
Call us
Purchase Full Report
Mini Report
$ 2969
$2699
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Single User License
$ 5499
$4999
-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Five User License
$ 6599
$5999
-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$ 7699
$6999
-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Why Expert Market Research?
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
NEWSLETTER